NKR-P1 biology: From prototype to missing self

Immunologic Research

Volumn 35, Issue 1-2, 2006, Pages 13-26

  Mesci, Aruz ^a   Ljutic, Belma ^a,c   Makrigiannis, Andrew P ^b   Carlyle, James R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c Immunology Research   (Canada)

Author keywords

CD161; Infection; KLR B1; Ly55; NK cell; NK1.1; Ocil Clr; Transformation

Indexed keywords

CD161 ANTIGEN; NATURAL KILLER CELL RECEPTOR;

CELL MEDIATED CYTOTOXICITY; CYTOKINE RELEASE; GENE STRUCTURE; GENETIC REGULATION; HUMAN; INNATE IMMUNITY; LIGAND BINDING; LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TRANSPLANTATION; TUMOR CELL; VIRUS INFECTION;

EID: 33749586462     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:35:1:13     Document Type: Review

References (88)

1. Glimcher L, Shen FW, Cantor H: Identification of a cellsurface antigen selectively expressed on the natural killer cell. J Exp Med 1977; 145:1-9.
2. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989; 47:187-376.
3. Lanier LL: NK cell recognition. Annu Rev Immunol 2005; 23:225-274.
4. Kumar V, McNerney ME: A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat Rev Immunol 2005; 5:363-374.
5. Hanna MG Jr, Tennant RW,Yuhas JM, Clapp NK, Batzing BL, Snodgrass MJ: Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma. Cancer Res 1972; 32:2226-2234.
6. Greenberg AH, Playfair JH: Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol 1974; 16:99-110.
7. Kiessling R, Bataillon G, Lamon EW, Klein E: The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts. Int J Cancer 1974; 14:642-648.
8. Kiessling R, Klein E,Wigzell H: "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5:112-117.
9. Kiessling R, Klein E, Pross H, Wigzell H: "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristic of the killer cell. Eur J Immunol 1975; 5:117-121.
10. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975; 16:216-229.
11. Herberman RB, Nunn ME, Holden HT, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975; 16:230-239.
12. Zarling JM, Nowinski RC, Bach FH: Lysis of leukemia cells by spleen cells of normal mice. Proc Natl Acad Sci USA 1975; 72:2780-2784.
13. Koo GC, Jacobson JB, Hammerling GJ, Hammerling U: Antigenic profile of murine natural killer cells. J Immunol 1980; 125:1003-1006.
14. Koo GC, Peppard JR, Hatzfeld A: Ontogeny of Nk-1+ natural killer cells. I. Promotion of Nk-1+ cells in fetal, baby, and old mice. J Immunol 1982; 129:867-871.
15. Koo GC, Peppard JR: Establishment of monoclonal anti-NK-1.1 antibody. Hybridoma 1984; 3:301-303.
16. Hackett J Jr, Tutt M, Lipscomb M, Bennett M, Koo G, Kumar V: Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells. J Immunol 1986; 136:3124-3131.
17. Sentman CL, Hackett JJ, Moore TA, Tutt MM, Bennett M, Kumar V: Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma 1989; 8:605-614.
18. Karlhofer FM, Yokoyama WM: Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. J Immunol 1991; 146:3662-3673.
19. Burton RC, Smart YC, Koo GC, Winn HJ: Studies on murine natural killer (NK) cells. V. Genetic analysis of NK cell markers. Cell Immunol 1991; 135:445-453.
20. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM: Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen. J Immunol 1990; 145:2353-2358.
21. Yokoyama WM, Ryan JC, Hunter JJ, Smith HR, Stark M, Seaman WE: cDNA cloning of mouse NKR-P1 and genetic linkage with Ly-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J Immunol 1991; 147:3229-3236.
22. Ryan JC, Turck J, Niemi EC, Yokoyama WM, Seaman WE: Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J Immunol 1992; 149:1631-1635.
23. Giorda R, Trucco M: Mouse NKR-P1. A family of genes selectively coexpressed in adherent lymphokine-activated killer cells. J Immunol 1991; 147:1701-1708.
24. Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC: Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 1989; 169:1373-1389.
25. Giorda R, Rudert WA,Vavassori C, Chambers WH, Hiserodt JC, Trucco M: NKR-P1, a signal transduction molecule on natural killer cells. Science 1990; 249: 1298-1300.
26. Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC, Seaman WE: NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J Immunol 1991; 147: 3244-3250.
27. Ryan J, Niemi E, Nakamura M, Seaman W: NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med 1995; 181:1911-1915.
28. Kung SK, Miller RG: The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro. J Immunol 1995; 154:1624-1633.
29. Ryan JC, Seaman WE: Divergent functions of lectin-like receptors on NK cells. Immunol Rev 1997; 155:79-89.
30. Carlyle JR, Zúñiga-Pflücker JC: Lineage commitment and differentiation of T and natural killer lymphocytes in the fetal mouse. Immunol Rev 1998; 165:63-74.
31. Carlyle JR, Martin A, Mehra A, Attisano L, Tsui FW, Zúñiga- Pflücker JC: Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol 1999; 162:5917-5923.
32. Kung SK, Su RC, Shannon J, Miller RG: The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J Immunol 1999; 162:5876-5887.
33. Liu J, Morris MA, Nguyen P, et al: Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. J Immunol 2000; 164:1793-1799.
34. Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH: Missing self recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci USA 2004; 101:3527-3532.
35. Iizuka K, Naidenko O, Plougastel B, Fremont D, Yokoyama WM: Genetically-linked C-type lectin-related ligands for the NKR-P1 NK cell receptors. Nat Immunol 2003; 4:801-807.
36. Ljutic B, Carlyle JR, Zúñiga-Pflücker JC: Identification of upstream cis-acting regulatory elements controlling lineage-specific expression of the mouse NK cell activation receptor, NKR-P1C. J Biol Chem 2003; 278:31909-31917.
37. Burke TW, Kadonaga JT: The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 1997; 11:3020-3031.
38. Georgopoulos K, Bigby M, Wang JH, et al: The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994; 79:143-156.
39. Samson SI, Richard O, Tavian M, et al: GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 2003; 19: 701-711.
40. Held W, Clevers H, Grosschedl R: Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition. Eur J Immunol 2003; 33:1393-1398.
41. Barton K, Muthusamy N, Fischer C, et al: The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 1998; 9:555-563.
42. Carlyle JR, Zúñiga-Pflücker JC: Requirement for the thymus in alpha beta T lymphocyte lineage commitment. Immunity 1998; 9:187-197.
43. Carlyle JR, Michie AM, Furlonger C, et al: Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med 1997; 186:173-182.
44. Carlyle JR, Michie AM, Cho SK, Zúñiga-Pflücker JC: Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny. J Immunol 1998; 160:744-753.
45. Carlyle JR, Zúñiga-Pflücker JC: Regulation of NK1.1 expression during lineage commitment of progenitor thymocytes. J Immunol 1998; 161:6544-6551.
46. Anderson SK: Transcriptional regulation of NK cell receptors. Curr Top Microbiol Immunol 2006; 298: 59-75.
47. Saleh A, Davies GE, Pascal V, et al: Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 2004; 21:55-66.
48. Plougastel B, Trowsdale J: Sequence analysis of a 62-kb region overlapyping the human KLRC cluster of genes. Genomics 1998; 49:193-199.
49. Chuang SS, Lee Y, Stepp SE, Kumaresan PR, Mathew PA: Molecular cloning and characterization of the promoter region of murine natural killer cell receptor 2B4. Biochim Biophys Acta 1999; 1447:244-250.
50. Kubo S, Itoh Y, Ishikawa N, Nagasawa R, Mitarai T, Maruyama N: The gene encoding mouse lymphocyte antigen Ly-49: structural analysis and the 5′-flanking sequence. Gene 1993; 136:329-331.
51. McQueen KL, Wilhelm BT, Takei F, Mager DL: Functional analysis of 5′ and 3′ regions of the closely related Ly49c and j genes. Immunogenetics 2001; 52:212-223.
52. Takei F, McQueen KL, Maeda M, et al: Ly49 and CD94/NKG2: developmentally regulated expression and evolution. Immunol Rev 2001; 181:90-103.
53. Wilhelm BT, McQueen KL, Freeman JD, Takei F, Mager DL: Comparative analysis of the promoter regions and transcriptional start sites of mouse Ly49 genes. Immunogenetics 2001; 53:215-224.
54. Saleh A, Makrigiannis AP, Hodge DL, Anderson SK: Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J Immunol 2002; 168:5163-5169.
55. Wilhelm BT, Landry JR, Takei F, Mager DL: Transcriptional control of murine CD94 gene: differential usage of dual promoters by lymphoid cell types. J Immunol 2003; 171:4219-4226.
56. Marusina AI, Kim DK, Lieto LD, Borrego F, Coligan JE: GATA-3 is an important transcription factor for regulating human NKG2A gene expression. J Immunol 2005; 174:2152-2159.
57. Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, Raulet DH: Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol 2004; 172:1074-1082.
58. Arase N, Arase H, Park SY, Ohno H, Ra C, Saito T: Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells. J Exp Med 1997; 186:1957-1963.
59. Arase H, Arase N, Saito T: Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J Exp Med 1996; 183:2391-2396.
60. Li J, Rabinovich BA, Hurren R, Shannon J, Miller RG: Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B. Int Immunol 2003; 15:411-416.
61. Ljutic B, Carlyle JR, Filipp D, Nakagawa R, Julius M, Zúñiga-Pflücker JC: Functional requirements for signaling through the stimulatory and inhibitory mouse NKR-P1 (CD161) NK cell receptors. J Immunol 2005; 174:4789-4796.
62. Campbell KS, Giorda R: The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues. Eur J Immunol 1997; 27:72-77.
63. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 1990; 60:755-765.
64. Lanier L, Chang C, Phillips J: Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994; 153:2417-2428.
65. Bezouska K, Yuen CT, Obrien J, et al: Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994; 372:150-157.
66. Bezouska K, Vlahas G, Horvath O, et al: Rat natural killer cell antigen, NKR-P1, related to C-type animal lectins is a carbohydrate-binding protein. J Biol Chem 1994:16945-16952.
67. Kogelberg H, Montero E, Bay S, Lawson AM, Feizi T: Re-evaluation of monosaccharide binding property of recombinant soluble carbohydrate recognition domain of the natural killer cell receptor NKR-P1A. J Biol Chem 1999; 274:30335-30336.
68. Kogelberg H, Lawson AM, Muskett FW, Carruthers RA, Feizi T: Expression in Escherichia coli, folding in vitro, and characterization of the carbohydrate recognition domain of the natural killer cell receptor NKR-P1A. Protein Expr Purif 2000; 20:10-20.
69. Yokoyama WM, Plougastel BF: Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003; 3:304-316.
70. Zhou H, Kartsogiannis V, Hu YS, et al: A novel osteoblast-derived C-type lectin that inhibits osteoclast formation. J Biol Chem 2001; 276:14916-14923.
71. Zhou H, Kartsogiannis V, Quinn JM, et al: Osteoclast inhibitory lectin, a family of new osteoclast inhibitors. J Biol Chem 2002; 277:48808-48815.
72. Plougastel B, Dubbelde C, Yokoyama WM: Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics 2001; 53:209-214.
73. Tian W, Nunez R, Cheng S, et al: C-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell proliferation and IL-2 production. Cell Immunol 2005; 234:39-53.
74. Tian W, Feng B, Liou HC: Silencing OCILRP2 leads to intrinsic defects in T cells in response to antigenic stimulation. Cell Immunol 2005; 235:72-84.
75. Boles KS, Barten R, Kumaresan PR, Trowsdale J, Mathew PA: Cloning of a new lectin-like receptor expressed on human NK cells. Immunogenetics 1999; 50:1-7.
76. Aldemir H, Prod'homme V, Dumaurier MJ, et al: Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 2005; 175:7791-7795.
77. Rosen DB, Bettadapura J, Alsharifi M, Mathew PA, Warren HS, Lanier LL: Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol 2005; 175:7796-7799.
78. Mathew PA, Chuang SS, Vaidya SV, Kumaresan PR, Boles KS, Pham HT: The LLT1 receptor induces IFN-gamma production by human natural killer cells. Mol Immunol 2004; 40:1157-1163.
79. Kaufman J, Milne S, Gobel TW, et al: The chicken B locus is a minimal essential major histocompatibility complex. Nature 1999; 401:923-925.
80. Shiina T, Shimizu S, Hosomichi K, et al: Comparative genomic analysis of two avian (quail and chicken) MHC regions. J Immunol 2004; 172:6751-6763.
81. Rogers SL, Gobel TW, Viertlboeck BC, Milne S, Beck S, Kaufman J: Characterization of the chicken C-type lectin-like receptors B-NK and B-lec suggests that the NK complex and the MHC share a common ancestral region. J Immunol 2005; 174:3475-3483.
82. Voigt S, Sandford GR, Ding L, Burns WH: Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus. J Virol 2001; 75: 603-611.
83. Giorda R, Weisberg EP, Tze KI, Trucco M: Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1. J Immunol 1992; 149: 1957-1963.
84. Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP: Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun 2005; 6:481-492.
85. Brown MG, Dokun AO, Heusel JW, et al: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001; 292:934-937.
86. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL: Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296: 1323-1326.
87. Idris AH, Smith HR, Mason LH, Ortaldo JR, Scalzo AA, Yokoyama WM: The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc Natl Acad Sci USA 1999; 96:6330-6335.
88. Carlyle JR, Mesci A, Ljutic B, et al: Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol 2006; 176: 7511-7524.